Cite
HARVARD Citation
Straub, T. et al. (n.d.). LB15. SER-109, an Investigational Microbiome Therapeutic, Reduces Abundance of Antimicrobial Resistance Genes in Patients with Recurrent Clostridioides difficile Infection (rCDI) after Standard-of-Care Antibiotics. Open forum infectious diseases. pp. S812-S813. [Online].